AJP - Lung Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 276: L213-L219, 1999;
1040-0605/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reeve, H. L.
Right arrow Articles by Weir, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reeve, H. L.
Right arrow Articles by Weir, E. K.
Vol. 276, Issue 2, L213-L219, February 1999

Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology

Helen L. Reeve1,2, Daniel P. Nelson3, Stephen L. Archer4, and E. Kenneth Weir2,3

Departments of 1 Physiology and 2 Medicine, University of Minnesota, Minneapolis 55455; 3 Department of Cardiology, Veterans Affairs Medical Center, Minneapolis, Minnesota 55417; and 4 Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2R7

The anorexic agents dexfenfluramine and fenfluramine plus phentermine have been associated with outbreaks of pulmonary hypertension. The fenfluramines release serotonin and reduce serotonin reuptake in neurons. They also inhibit potassium current (IK), causing membrane potential depolarization in pulmonary arterial smooth muscle cells. The recent withdrawal of the fenfluramines has led to the use of fluoxetine and phentermine as an alternative anorexic combination. Because fluoxetine and venlafaxine reduce serotonin reuptake, we compared the effects of these agents with those of phentermine and dexfenfluramine on pulmonary arterial pressure, IK, and membrane potential. Fluoxetine, venlafaxine, and phentermine caused minimal increases in pulmonary arterial pressure at concentrations < 100 µM but did cause a dose-dependent inhibition of IK. The order of potency for inhibition of IK at +50 mV was fluoxetine > dexfenfluramine = venlafaxine > phentermine. Despite the inhibitory effect on IK at more positive membrane potentials, fluoxetine, venlafaxine, and phentermine, in contrast to dexfenfluramine, had minimal effects on the cell resting membrane potential (all at a concentration of 100 µM). However, application of 100 µM fluoxetine to cells that had been depolarized to -30 mV by current injection elicited a further depolarization of >18 mV. These results suggest that fluoxetine, venlafaxine, and phentermine do not inhibit IK at the resting membrane potential. Consequently, they may present less risk of inducing pulmonary hypertension than the fenfluramines, at least by mechanisms involving membrane depolarization.

anorexic; serotonin; potassium channels; pulmonary hypertension; membrane potential


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Rezaie-Majd, J. Murar, D. P. Nelson, R. F. Kelly, Z. Hong, I. M. Lang, A. Varghese, and E. K. Weir
Increased release of serotonin from rat ileum due to dexfenfluramine
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1209 - R1213.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Drent, S. Singh, A. P. M. Gorgels, D. M. Hansell, O. Bekers, A. G. Nicholson, R. J. van Suylen, and R. M. du Bois
Drug-induced Pneumonitis and Heart Failure Simultaneously Associated with Venlafaxine
Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 958 - 961.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. L. Reeve, S. L. Archer, M. Soper, and E. K. Weir
Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential
Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L662 - L666.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online